Literature DB >> 19533683

The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease.

Diego F Calvisi1, Federico Pinna, Sara Ladu, Maria R Muroni, Maddalena Frau, Ilaria Demartis, Maria L Tomasi, Marcella Sini, Maria M Simile, Maria A Seddaiu, Francesco Feo, Rosa M Pascale.   

Abstract

Previous work showed a genetic control of cell cycle deregulation during hepatocarcinogenesis. We now evaluated in preneoplastic lesions, dysplastic nodules and hepatocellular carcinoma (HCC), chemically induced in genetically susceptible F344 and resistant Brown Norway (BN) rats, the role of cell cycle regulating proteins in the determination of a phenotype susceptible to HCC development. p21(WAF1), p27(KIP1), p57(KIP2) and p130 mRNA levels increased in fast growing lesions of F344 rats. Lower/no increases occurred in slowly growing lesions of BN rats. A similar behavior of RassF1A mRNA was previously found in the 2 rat strains. However, p21(WAF1), p27(KIP1), p57(KIP), p130 and RassF1A proteins exhibited no change/low increase in the lesions of F344 rats and consistent rise in dysplastic nodules and HCC of BN rats. Increase in Cks1-Skp2 ligase and ubiquitination of cell cycle regulators occurred in F344 but not in BN rat lesions, indicating that posttranslational modifications of cell cycle regulators are under genetic control and contribute to determine a phenotype susceptible to HCC. Moreover, proliferation index of 60 human HCCs was inversely correlated with protein levels but not with mRNA levels of P21(WAF1), P27(KIP1), P57(KIP2) and P130, indicating a control of human HCC proliferation by posttranslational modifications of cell cycle regulators.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19533683     DOI: 10.1002/ijc.24650

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma.

Authors:  Diego F Calvisi; Matthias Evert; Frank Dombrowski
Journal:  Mol Biol Int       Date:  2012-04-02

2.  Cks1: Structure, Emerging Roles and Implications in Multiple Cancers.

Authors:  Vinayak Khattar; Jaideep V Thottassery
Journal:  J Cancer Ther       Date:  2013-10-01

3.  SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice.

Authors:  Salvatore Delogu; Chunmei Wang; Antonio Cigliano; Kirsten Utpatel; Marcella Sini; Thomas Longerich; Nina Waldburger; Kai Breuhahn; Lijie Jiang; Silvia Ribback; Frank Dombrowski; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Oncotarget       Date:  2015-02-10

4.  Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.

Authors:  Xiang Wang; Qiaohua Ren; Tao Wu; Yong Guo; Yong Liang; Subo Liu
Journal:  Mol Med Rep       Date:  2014-10-10       Impact factor: 2.952

Review 5.  New insights on the role of epigenetic alterations in hepatocellular carcinoma.

Authors:  Maddalena Frau; Claudio F Feo; Francesco Feo; Rosa M Pascale
Journal:  J Hepatocell Carcinoma       Date:  2014-06-12

Review 6.  Experimental Models to Define the Genetic Predisposition to Liver Cancer.

Authors:  Rosa M Pascale; Maria M Simile; Graziella Peitta; Maria A Seddaiu; Francesco Feo; Diego F Calvisi
Journal:  Cancers (Basel)       Date:  2019-09-27       Impact factor: 6.639

7.  MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.

Authors:  Sweta Mishra; Chun-Lin Lin; Tim H-M Huang; Hakim Bouamar; Lu-Zhe Sun
Journal:  Mol Cancer       Date:  2014-09-12       Impact factor: 27.401

8.  Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.

Authors:  Haohai Zhang; Chengpei Zhu; Yi Zhao; Ming Li; Liangcai Wu; Xiaobo Yang; Xueshuai Wan; Anqiang Wang; Michael Q Zhang; Xinting Sang; Haitao Zhao
Journal:  Oncotarget       Date:  2015-12-22

9.  Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.

Authors:  Jie Zhang; Qianqian Song; Jinxia Liu; Lina Lu; Yuqing Xu; Wenjie Zheng
Journal:  Dis Markers       Date:  2019-10-22       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.